Objective Non-simple nodules in hepatocellular carcinoma (HCC) correlate with poor prognosis. Therefore, we examined the diagnostic ability of gadolinium-ethoxybenzyldiethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging (EOB-MRI) and contrast-enhanced ultrasound (CEUS) for diagnosing the macroscopic classification of small HCCs. Methods A total of 85 surgically resected nodules (≤30 mm) were analyzed.
Introduction
Hepatocellular carcinoma (HCC) is one of the most common malignancies in the world. Despite recent advances in diagnostic modalities and therapies, the long-term survival in patients with HCC has been poor because of the high incidence of recurrence after initial treatment [1] [2] [3] [4] . Macroscopic classification of HCCs is known to be a significant prognostic factor, and also, an important factor for both survival and recurrence rates after initial treatment. Especially, the non-simple nodular (SN) type of HCCs shows an intense correlation with poor prognosis because of its higher frequency of microvascular invasion (MVI) and intrahepatic metastasis compared with the SN type [5] [6] [7] [8] [9] [10] [11] . Therefore, the diagnosis of non-SN would be useful for deciding on the treatment strategy of small HCCs equal to or less than 30 mm, which are usually an indication for either surgical resection or local treatment, such as radiofrequency ablation and percutaneous ethanol injection therapy. Namely, systematized hepatectomy is preferable as a curative treatment in cases of non-SN. Local treatment is not recommended as an initial treatment because of the high recurrence rate [8] [9] [10] . Currently, the macroscopic classification is conventionally done by the resected specimens of HCCs. Accordingly, the accurate prediction of macroscopic classifications other than histological findings of resected specimens, are important for the management of HCCs before treatment. Recently, the gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging (EOB-MRI) [12] [13] [14] [15] [16] [17] and contrast-enhanced ultrasound (CEUS) [18] [19] [20] [21] are available as imaging modalities for diagnosing HCCs in addition to abdominal ultrasound (US), contrast-enhanced computed tomography (CECT) and angiography-assisted CT. EOB-MRI and CEUS have provided high degrees of detectability for small HCCs [22, 23] . In addition, they have been reported as useful methods to predict macroscopic findings [24] [25] [26] [27] . However, it is unclear which imaging modalities are most suitable to assess the macroscopic findings. So far, no study has investigated the diagnostic ability of the macroscopic findings by using a combination of both modalities.
The aim of this study was to examine the diagnostic ability of EOB-MRI, CEUS, and both modalities for diagnosing macroscopic findings of small HCCs. In particular, we focused on the diagnostic ability to identify non-SN, as it shows an intense correlation with poor prognosis.
Materials and methods

Patients
Four hundred and seventy-seven HCC patients who received curative hepatic resection at the Hiroshima University Hospital between October 2003 and November 2013 were enrolled in this study. The diagnosis of HCC was based on postoperative pathological confirmation. Inclusion criteria were as follows: (1) HCCs equal or less than 30 mm in maximum diameter, (2) no preoperative treatment for HCCs such as transarterial chemoembolization, radiofrequency ablation was performed, (3) both EOB-MRI and CEUS were preoperatively performed, (4) the main tumour was precisely evaluated by both EOB-MRI and CEUS. In patients with multiple HCCs, a main tumour was subjected for analysis. Finally, 85 nodules in 85 patients met these criteria and were included in the present retrospective study (Fig. 1) .
Clinical features of 85 patients are shown in Table 1 . Sixtythree patients were men and 22 were women, with a median age of 66 (33-88) years. Forty-three patients (50.6 %) were positive for hepatitis C virus (HCV) antibody, 17 patients (20 %) were positive for hepatitis B surface antigen, and 25 patients (29.4 %) were negative for both markers. Liver cirrhosis was present in 27 patients (31.7 %). Liver function was evaluated with the Child-Pugh classification system, with all patients classified as A.
EOB-MRI
We used a 3-T system using an 8-channel body coil plus 4-channel flex coil (Vantage Titan 3T: Toshiba Medical Systems, Ohtawara, Japan). Dynamic MRI study was performed with fat-suppressed T1-weighted gradient-echo imaging with 3D fast field echo. The acquisition parameters were section thickness and interval 5 (or 4) mm, TR/TE 3.7 ms/1.3 ms, FA 15°, field-of-view 36 cm, matrix 224×192, parallel imaging factor 2, acquisition time 18 s. Hepatobiliary phase (HBP) was acquired using the following sequences: section thickness and interval 3 mm, TR/TE 3.7 ms/1.3 ms, FA 15°, field-of-view 36 cm, matrix 320×192, parallel imaging factor 2, acquisition time 22 s. After pre-enhanced imaging, we injected Gd-EOB-DTPA intravenously and acquired four-phase Gd-EOB-DTPA-enhanced examinations of the liver during the arterial-phase (AP), portal venous-phase (PVP), transitionalphase, and HBP. The imaging timing for AP was determined by test injection of 0.5 ml Gd-EOB-DTPA. Imaging during AP was at aortic transit time, calculated from test injection images plus 7 s after the start of the Gd-EOB-DTPA injection. Imaging during PVP and HBP was at 1 and 20 min after the Gd-EOB-DTPA injection. We administered Gd-EOB-DTPA at a dose of 25 μmol/kg and at a rate of 2.0 ml/s and flushed with 20 ml saline using a power injector (Sonic Shot 50; Nemoto-Kyorindo, Tokyo, Japan). The imaging diagnosis of HCC with EOB-MRI was based on hypervascularity in the arterial phase and defect in the HBP.
CEUS
All CEUS were performed by two sonographers with more than 5 years of experience in abdominal US. CEUS was performed using a HI VISION Ascendus (Hitachi Medical Corporation, Tokyo, Japan) and a microconvex probe (EUP-C715, 3.5 MHz; Hitachi Medical Corporation, Tokyo, Japan). The wide-band pulse-inversion harmonic imaging mode was employed. The acoustic power of the harmonic ultrasound was set at a mechanical index of 0.16-0.2. The dynamic range was fixed at 60-65 dB. The focus point was set at the deep site of the lesion. The real-time images were stored on hard disk so that the images could be recalled as necessary. The indocyanine green retention rate at 15 min, AFP α-fetoprotein, DCP des-r-carboxyprothrombin sonographic contrast agent was Sonazoid (Daiichi Sankyo, Tokyo, Japan). The suspension (0.015 ml/kg body weight) was injected into an antecubital vein through a 22-gauge cannula at a speed of approximately 1 ml/s and immediately flushed with 5-10 ml of normal saline. After injection of Sonazoid, the patients were asked to hold their breath. The images of the ideal imaging plane were displayed in realtime mode for all phases. We defined the vascular phases as follows: early vascular phase, 10-30 s after contrast injection; late vascular phase, 30-120 s after contrast injection; postvascular (Kupffer) phase, 10 min or more after contrast injection. Tumour enhancement was depicted in the early and late vascular phase, whereas parenchymal uptake of contrast agent was evaluated in the Kupffer phase. The imaging diagnosis of HCC with CEUS was based on hypervascularity in the early vascular phase and detected in the Kupffer phase.
Pathological assessment of macroscopic findings
We defined tumour size as the maximum diameter of the resected tumour specimen. In accordance with the classification proposed by the General Rules of the Clinical and Pathological Study of Primary Liver Cancer in Japan [28] , macroscopic findings of resected specimens were divided into the following five types by experienced surgeons: (i) small nodular type with indistinct margin (SN-IM), (ii) simple nodular type with distinct margin (SN-DM), (iii) simple nodular type with extranodular growth (SN-EG), (iv) confluent multinodular type (CMN), (v) infiltrative type (IF).
Imaging assessment of macroscopic findings
The macroscopic findings by imaging studies were defined as tumours characterized by a clear border between tumour and surrounding parenchyma. We retrospectively reviewed both EOB-MRI and CEUS studies and classified the imaging findings of 85 nodules into the following five gross types corresponding to the pathological macroscopic findings ( In accordance with these definitions, two expert hepatologists who were blinded to the patients' clinical backgrounds or pathologic results, categorized each main nodule into SN or non-SN by evaluating HBP of EOB-MRI and Kupffer phase of CEUS independently. Predictions of macroscopic findings by imaging modalities were assessed individually or in combination. When the assessed type did not match, the reviewers assessed together and discussed to reach consensus on the diagnosis.
Statistical analysis
All values were expressed as mean±SD or median (range). We analyzed for associations between macroscopic findings and tumour factors. Comparisons between SN and non-SN groups were performed by the Mann-Whitney U test for continuous variables, and Fisher's exact test for categorical variables. The imaging macroscopic findings were compared with the pathological macroscopic findings, and the diagnostic ability of EOB-MRI, CEUS, and in combination, was assessed by using receiver operating characteristic (ROC) curves [29] . The area under the ROC curve (AUROC) was classified as low accuracy (0.50-0.70), moderate accuracy (0.70-0.90), and high accuracy (0.90-1.0) [30] . The sensitivity, specificity, positive predict value (PPV), negative predict value (NPV), and accuracy for identifying non-SN were calculated. Fisher's exact test was used to compare sensitivity, specificity, PPV, NPV, and accuracy. Concordance rates using kappa statistics between two hepatologists were calculated. A kappa value of 0.20 or less indicated poor agreement; 0.21-0.40, fair agreement; 0.41-0.60, moderate agreement; 0.61-0.80, good agreement; and 0.81-1.00, excellent agreement [31] . A value of p<0.05 was considered statistically significant. Statistical analyses were performed using SPSS computer software (SPSS version 12 for Windows; SPSS Japan Inc., Tokyo, Japan).
Results
Pathological features of HCCs
Among 85 HCC nodules, two tumours (2.4 %) were classified into SN-IM, 44 (51.8 %) tumours into SN-DM, 27 (31.8 %) tumours into SN-EG, nine (10.6 %) tumours into CMN, and three (3.5 %) tumours into IF from the resected specimen (Table 2) . 
Association between macroscopic findings and tumour factors
When we analyzed the association between macroscopic findings and tumour factors (Table 3) , serum DCP level (p=0.007), tumour size (p=0.002), and the presence of MVI (p=0.018) were found to be significantly associated with non-SN in small HCCs. The presence of intrahepatic micrometastasis tended to have a higher frequency in non-SN than in SN, although the difference was not statistically significant (p=0.089). With regard to other variables, there were no significant differences between SN and non-SN in the present study.
ROC curves for the diagnosis of non-SN
The ROC curves for diagnosing non-SN with EOB-MRI, CEUS, and in combination of both were shown in Fig. 3 . The AUROCs (95 % confidence interval [CI]) in the category of all sizes were as follows ( The combined diagnosis by EOB-MRI and CEUS provides higher diagnostic ability in all three categories (all sizes, ≤20 mm, >20 mm) compared with an individual imaging modality, though the differences were not statistically significant. Diagnostic ability of imaging modalities for the diagnosis of non-SN Table 4 shows the sensitivity, specificity, PPV, NPV, and accuracy of EOB-MRI, CEUS, and in combination of both for diagnosing non-SN. The sensitivity, specificity, PPV, NPV, and accuracy of EOB-MRI and CEUS were statistically equal in all three categories (all sizes, ≤20 mm, >20 mm). On the other hand, the sensitivity and accuracy in combination of both modalities were higher than those of the individual modality in all three categories. The sensitivity was especially statistically significant compared with CEUS in the category of all sizes and HCCs ≤20 mm (p=0.014, 0.036).
In the present study, misclassified nodules were 18. (Fig. 4) . Thus, most disagreement came from underestimation. On the other hand, misclassified nodules were minimized to 8.2 % (7/85) when diagnosed in combination of both modalities.
Interobserver variability in the assessment for non-SN by imaging modalities
Moderate agreement was obtained for all three categories in EOB-MRI (kappa value=0.717, 0.657, and 0.621 for all sizes, HCCs ≤20 mm, and HCCs >20 mm, respectively) and for all sizes and HCCs >20 mm in CEUS (kappa value=0.638 and 0.688 for all sizes and HCCs >20 mm). Fair agreement was obtained for HCCs ≤20 mm in CEUS (kappa value=0.546).
Discussion
In the present study, a higher frequency of MVI and intrahepatic metastasis of non-SN in small HCCs compared with SN was compatible with previous reports [5] [6] [7] [8] [9] [10] [11] . We examined the diagnostic ability of EOB-MRI, CEUS, and a combination of both modalities for diagnosing non-SN. The individual diagnostic ability of EOB-MRI and CEUS for diagnosing non-SN was statistically equal. Furthermore, the AUROCs of EOB-MRI and CEUS for diagnosing non-SN were greater than 0.7 which corresponds to a moderate diagnostic value (Fig. 3) . These results suggest that both EOB-MRI and CEUS could be useful imaging modalities for diagnosing non-SN. On the other hand, high diagnostic ability for diagnosing non-SN was obtained when diagnosed in a combination of both modalities (AUROCs=greater than 0.85 which corresponds to a moderate diagnostic value) (Fig. 3) . Especially, AUROCs were greater than 0.9 in HCCs >20 mm, and considered to be of high diagnostic value. Furthermore, the sensitivity and accuracy for diagnosing non-SN in combination with both modalities improved compared with those of individual modality in all three categories. The sensitivity was especially statistically significant compared with CEUS in the category of all sizes and HCCs ≤20 mm ( Table 4) .
The advantages of EOB-MRI for diagnosing macroscopic findings are high contrast resolution in HBP, objectivity, and reproducibility. Fujinaga et al. reported that EOB-MRI is one of the useful methods to predict macroscopic findings because it can clearly demonstrate the border between the tumour and the surrounding liver parenchyma [26] . In the present study, the extranodular growth of non-SN was depicted clearly as a low signal area projecting from the nodule even if less than 20 mm in size (Fig. 5) , though it also has some disadvantages: (1) using thicker slice thickness than CECT (low spatial resolution), (2) low contrast resolution in poor liver function, (3) extranodular growth and blood vessels surround nodules are depicted as same low intensity area in HBP. On the other hand, CEUS is also useful for diagnosing the macroscopic findings [24, 27] . The advantage of CEUS is high spatial, temporal, and contrast resolution [24] and Kupffer imaging clearly shows the tumour contours according to the shape of defect [32, 33] . In addition, multiple views (i.e. axial, coronal, and sagittal views) are available. There are some disadvantages:
(1) it is strongly influenced by technique of tester and build of the subject (lack of objectivity and reproducibility), (2) low contrast resolution in poor liver function, (3) There are difficult areas to detect a tumour, due to artefacts (deep part, marginal part, right under diaphragm in liver). In the present study, five nodules could not be detected by CEUS due to the abovementioned reasons and were excluded from this study, whereas EOB-MRI could detect all these nodules. However, if targeted nodules are detected on good contrast condition by CEUS, it might have higher time and spatial resolution than EOB-MRI (Fig. 5) . Therefore, it is important to understand the characteristic of each imaging modality for the diagnosis of macroscopic findings. EOB-MRI and CEUS are superior modalities for diagnosing macroscopic findings [24] [25] [26] [27] . However, they have some limitations. In the present study, misclassified nodules were 18.8 % (16/85) in EOB-MRI, and 21.2 % (18/85) in CEUS. Most of the misdiagnosis came from underestimation of non-SN as SN (Fig. 4) , and this is a bigger clinical problem than overestimation of SN as non-SN. This would mean that the extranodular growth of non-SN was not correctly diagnosed in most misdiagnosed cases, due to the low sensitivity for diagnosing non-SN (Table 4) . Based on the present study showing the PPV for diagnosing non-SN was relatively high in all three categories, the detection of the extranodular growth could lead to correct diagnosis. Therefore, the improvement of sensitivity for diagnosing the extranodular growth is a key to improve the diagnostic ability for diagnosing non-SN. Mainly, we speculate that there are three problems for the misdiagnosis in both modalities. First, in spite of good contrast between the tumour and background liver, it is difficult to detect the extranodular growth due to the lack of spatial resolution of each modality. Second, the extranodular growth is not detected due to poor contrast-enhancement. Finally, it is difficult to distinguish the irregularity around the nodule from the septum formation of SN and the extranodular growth of non-SN. This decision greatly depends on the subjectivity of readers and lacks in objectivity because a criterion for determining the extranodular growth is not clear. These problems mostly influence the diagnosis for HCCs ≤20 mm in CEUS because smaller tumour size causes lower spatial and contrast resolution and the objectivity of CEUS is lower than the objectivity of EOB-MRI. Thus, we thought that they resulted in the lower sensitivity of CEUS for diagnosing non-SN compared to EOB-MRI (Table 4 , p=0.302) and fair interobserver agreement in the category of HCCs ≤20 mm.
The diagnosis for non-SN by using current individual modalities has some limitations. As Fujinaga et al. pointed out, with advances in technology, we will be able to make a more precise diagnosis on thin slice and high resolution images [26] . We think that another solution strategy of using current modalities is a combined diagnosis of imaging modalities. As described above, each modality has advantages and disadvantages in the diagnosis of the macroscopic findings. The combined diagnosis might have supplemented the disadvantage of each modality. In fact, the results of this study suggested that the combined diagnosis by both EOB-MRI and CEUS for diagnosing non-SN was superior to individual assessment. Therefore, we think that it is desirable for the final diagnosis of non-SN to be diagnosed after evaluating by multiple imaging modalities.
The present study has several limitations. First, our study is retrospective and involved a relatively small number of patients in a single facility. Second, all patients were Child-Pugh class A, which suggests they had good hepatic reserve. If many Child-Pugh class B or C patients with poor hepatic reserve were included, the diagnostic ability of EOB-MRI and CEUS for diagnosing non-SN might decrease. Third, the assessment using reconstruction images (coronal, sagittal section) in EOB-MRI and the combination of arterial phase and HBP in EOB-MRI or arterial phase and Kupffer phase in CEUS might have improved the diagnostic ability [27] . Further studies will be necessary to verify our results in a larger number of patients. Fourth, this study lacks the data of prognosis in patients with non-SN diagnosed by EOB-MRI and/or CEUS. In the future, it is necessary to identify survival and recurrence rates in patients with non-SN diagnosed by EOB-MRI and/or CEUS.
In conclusion, accurate assessment for determining non-SN by imaging modalities is important for the deciding on the treatment strategy and the estimates of prognosis in small HCCs. Combined diagnosis by EOB-MRI and CEUS could provide high-quality imaging assessment for determining non-SN in small HCCs.
